Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford hosts Belgian vaccine experts

Department General Vaccinology

Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.

Advancing a malaria vaccine for better global health outcomes

Department General Vaccinology

Professor Sue Ann Costa Clemens CBE, Chair of Global Health at the Department of Paediatrics and Head of Oxford Latam Research Group – a collaboration between Oxford and Brazil, aimed at strengthening our commitment to global health – met with His Excellency Antonio Patriota, Brazilian Ambassador to the UK, to discuss the co-development of a Malaria vaccine and advance public health outcomes in Brazil.

New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites

Clinical Trials Research Research Methods Vaccinology

Scientists at the University of Oxford and the University of Edinburgh have launched a pioneering study that examines how the immune system responds to repeated malaria infections. The BIO-004 study is being run in partnership between the Department of Biochemistry (Draper Lab, based in the Kavli Institute for Nanoscience Discovery), the University of Edinburgh (Spence Lab, Institute of Immunology and Infection Research) and the Oxford Vaccine Group (part of the Department of Paediatrics). BIO-004 will provide a unique insight into how the immune system adapts over the first few malaria infections of life, learning to tolerate malaria parasites and developing natural immunity to severe illness.

Research shows comforting babies eases parental stress in painful procedures

Neuroimaging Parents & Carers Research

The Neuroimaging Group, at the Department of Paediatrics, in collaboration with Bliss, the charity for babies born premature or sick, has launched a new suite of information resources for parents of neo-nates, designed to make them feel more confident about being involved in the care of their babies.

Student wins award for Individual Excellence in Clinical Data Management

Awards & Appointments Clinical Trials Department

Yama Mujadidi, DPhil student and Clinical Trials IT & Development Lead at the Oxford Vaccine Group, has been awarded the prize for Individual Excellence by the Association for Clinical Data Management.

Novartis Global Scholar Program award for Neuromuscular team

Awards & Appointments Department Neuromuscular Diseases Research

Many congratulations to Associate Professor Carlo Rinaldi and Senior Postdoctoral Scientist Antonio Garcia-Guerra, who have been awarded the Novartis Global Scholar Program (NGSP) for 2023.

Shining a light on Rare Disease

Department General Public Engagement

The chapel facade of Magdalen College, Oxford, was awash with colour this evening to raise awareness of the plight of those living with rare disease.

Clinical Lecturer in Paediatrics selected as finalist for the MRC Impact Prize 2023: Early Career Impact

Awards & Appointments Department Public Engagement Research

Dr Michelle Fernandes, a Clinical Lecturer at the Department of Paediatrics, Research Fellow at the Nuffield Department of Women’s & Reproductive Health, and Associate Fellow at Green Templeton College has been selected as a finalist for the Medical Research Council (MRC) Impact Prize 2023, for her cross-disciplinary research in international early child development.

New animation series to support parents of premature infants

Children's Health Department Neuroimaging Parents & Carers Public Engagement Research

Professor Caroline Hartley, Principal Investigator, and Dr Marianne van der Vaart Postdoctoral Researcher, in the Paediatric Neuroimaging Group at the Department of Paediatrics, have today launched a series of animations aimed at improving parental understanding of brain development in premature infants, and the effect it has on breathing and apnoeas (the cessation of breathing).

New protein discovery sheds light on complexity of genetic regulation

Department Publication Research

Scientists at the Department of Paediatrics have discovered a new pathway that the human body uses to silence transposable elements or ‘jumping genes’. Dr. Rebecca Berrens, Principal Investigator in the Transposon Group, has published research into the piRNA pathway, a key process our body uses to keep these transposable elements in check.

Associate Professor Carlo Rinaldi awarded prestigious Clinical Fellowship

Awards & Appointments Department Neuromuscular Diseases Research

Associate Professor Carlo Rinaldi, a Consultant Neurologist and Clinician Scientist at the Department of Paediatrics, has been awarded the prestigious UKRI MRC Senior Clinical Fellowship for 2024.

Oxford University professors on the record with their contribution to the fight against cancer for this World Cancer Day

Department Haematology Research University

This World Cancer Day, four Principal Investigators from the University of Oxford, including Andi Roy, Professor of Paediatric Haematology at the Department of Paediatrics, talk candidly about their work and how they’re helping the fight against cancer.

Oxford University Professors to lecture on new course in 'Translational Science' at three Brazilian institutions

Department Research Methods Teaching University Vaccinology

The Department of Paediatrics at the University of Oxford, has entered into an agreement with three Brazilian Universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024.

MDUK Oxford Neuromuscular Centre celebrates five year anniversary

Clinical Trials Department Neuromuscular Diseases Research

The Department of Paediatrics at the University of Oxford is celebrating the five-year anniversary of a partnership with MDUK. Founded in January 2019, the MDUK Oxford Neuromuscular Centre was set up to drive the development of new therapies and treatments and increase the capacity of clinical trials for muscle wasting and weakening conditions in the UK.

FCDO Minister meets with vaccine researchers

COVID-19 Department Public Engagement University Vaccinology

Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

First in-human vaccine trial for Nipah virus

Clinical Trials Immunology Research Vaccinology

The University of Oxford has launched a new clinical trial to test a vaccine against the deadly Nipah virus.

DoP professor named in New Year's Honours list

Awards & Appointments COVID-19 University

Matthew Snape, Professor of Paediatrics and Vaccinology at the Oxford Vaccine Group (OVG) before moving to Moderna in August 2022, has been appointed Member of the Most Excellent Order of the British Empire (MBE) for services to Public Health, particularly during COVID-19 while working at the OVG.

OVG receives £7.8 million in research funding to fight pandemic and epidemic threats

COVID-19 Research Vaccinology

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

New campaign by Oxford Vaccine Group hopes to boost jab numbers

COVID-19 Clinical Trials Public Engagement Vaccinology

Experts have launched a new campaign in a bid to boost waning vaccine uptake by giving people more information about how clinical trials work. Researchers hope to alleviate hesitancy by showing with a simple animation and comic the complex way vaccines are developed.

Chancellor announces support for Rare Therapies Launch Pad

Children's Health Department Public Engagement

The Chancellor's Autumn statement announced government support for the Rare Therapies Launch Pad, a new programme within the Department of Paediatrics designed to develop regulatory pathways for children with rare conditions to access individualised therapies.

Load More